Get started
Author

Luke Ames

Observed names: Ames, Luke, L Ames, L. Ames
Observed institution: University of Birmingham
ORCID: 0009-0004-5126-6746
Observed ORCID: 0009-0004-5126-6746
OpenAlex ID: A5048855270
Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth
2024 · Sophie G. Kellaway, Sandeep Potluri, et al. · Nature Communications · 41
PDF
RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction
2019 · Anetta Ptasinska, Anna Pickin, et al. · Cell Reports · 38
PDF
A genome-wide relay of signalling-responsive enhancers drives hematopoietic specification
2023 · B. Edginton-White, A. Maytum, et al. · Nature Communications · 26
PDF
Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia
2022 · Assunta Adamo, Paulynn Chin, et al. · Leukemia · 21
PDF
Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth
2023 · Daniel J.L. Coleman, Peter Keane, et al. · Cell Reports · 14
Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1
2024 · Daniel J.L. Coleman, Peter Keane, et al. · iScience · 11
Detection of genome-wide methylation changes in bladder cancer by long-read sequencing of urinary DNA
2025 · Anshita Goel, Benjamin J. Tura, et al. · Clinical Epigenetics · 5
PDF
P20 Long-read sequencing increases the diagnostic rate for rare diseases
2026 · Lorraine Hartles-Spencer, H Titheradge, et al. · Journal of Medical Genetics · 3
PDF
RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction
2019 · Anetta Ptasinska, Anna Pickin, et al. · Cell Reports · 3
Ceralasertib plus Durvalumab in Ras Mutant and Ras Wild-Type Advanced Non–Small Cell Lung Cancer: Two Cohorts of the Phase II Platform National Lung Matrix Trial
2026 · Gary Middleton, Richard Buchanan, et al. · Clinical Cancer Research
101 Independent replication and validation of nanopore-based long read sequencing and methylome classification for rapid brain tumour diagnosis
2026 · Vassili Crispi, Luke Ames, et al. · Neuro-Oncology
PDF
Development of receptor and oncogene-responsive luciferase reporter vectors that are activated via kinase signaling to AP-1
2026 · Daniel J.L. Coleman, Luke Ames, et al. · Experimental Hematology
Epco-38. Independent Replication of Use of Nanopore-based Diagnostic Assay for Rapid Brain Tumour Diagnosis
2025 · Victoria Wykes, Vassili Crispi, et al. · Neuro-Oncology
PDF
Pass-through of energy price shocks in an Australian context
2025 · Luke Ames
3113 – Leukaemic Stem Cells Cell Hijack Lineage Inappropriate Signalling Pathways to Activate Growth
2022 · Sophie Kellaway, Sandeep Potluri, et al. · Experimental Hematology
1005 – a Genome-wide Relay of Signalling-responsive Enhancers Drives Hematopoietic Specification
2022 · Constanze Bonifer, Luke Ames, et al. · Experimental Hematology
3132 – Identification of Signalling-responsive Cis-regulatory Elements Regulating Blood Development
2022 · Alexander Maytum, Luke Ames, et al. · Experimental Hematology
Works count: 21
Citation count: 162
H-index: 6
I10-index: 6
Year
Topic
Type